Belmont, MA, United States of America

Steven C Polomoscanik

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
5 patents (USPTO):

Title: The Innovations of Steven C. Polomoscanik

Introduction

Steven C. Polomoscanik is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of cationic polymers, with a focus on their applications in treating metabolic and gastrointestinal disorders. With a total of 5 patents to his name, Polomoscanik's work is recognized for its innovative approach and practical applications.

Latest Patents

Among his latest patents is the invention titled "Substituted phenyl boronic acid containing polymers and methods of use." This patent discloses cationic polymers that are functionalized with substituted phenylboronic acid groups. The methods outlined in this patent aim to utilize these polymers for treating various metabolic and gastrointestinal disorders. This innovative approach highlights the potential of his work in addressing significant health challenges.

Career Highlights

Polomoscanik's career is marked by his dedication to research and development in the field of polymer science. His work at Glyscend, Inc. has allowed him to explore the intersection of chemistry and medicine, leading to advancements that could improve patient outcomes. His expertise in polymer functionalization has positioned him as a key figure in his area of specialization.

Collaborations

Some of his notable coworkers include Thomas Henry Jozefiak and Ashish Nimgaonkar. Their collaborative efforts contribute to the innovative environment at Glyscend, Inc., fostering advancements in polymer research and applications.

Conclusion

Steven C. Polomoscanik's contributions to the field of cationic polymers and their applications in medicine underscore his role as a leading inventor. His innovative patents and collaborative work continue to pave the way for advancements in treating metabolic and gastrointestinal disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…